Tuesday, August 16, 2022
ChemoCentryx (NASDAQ: CCXI) to be Acquired by Amgen (NASDAQ: AMGN) for $3.7 Billion in Cash
ChemoCentryx, Inc. (NASDAQ: CCXI) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization of...
Read more
Poseida Therapeutics (NASDAQ: PSTX) Enters into Strategic Collaboration Agreement with Roche to Develop Next-Gen Allogeneic CAR-T Cell Therapies
Poseida Therapeutics, Inc. (NASDAQ: PSTX) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development...
Read more
Applied DNA Sciences (NASDAQ: APDN) Begins Validation Testing of its Monkeypox Virus PCR Diagnostic Test
Applied DNA Sciences, Inc. (NASDAQ: APDN) is a biotechnology company that is focused on producing and developing polymerase chain reaction...
Read more
Better Therapeutics (NASDAQ: BTTX) Says Pivotal Trial of BT-001 Met Positive Primary and Secondary Endpoints for Type 2 Diabetes
Better Therapeutics, Inc. (NASDAQ: BTTX) is engaged as a prescription digital therapeutics company, which is focused on the research and...
Read more
Hanger (NYSE: HNGR) Enters Into Agreement to Be Acquired by Patient Square Capital for $18.75 Per Share in Cash, Implying Enterprise Value of $1.25 Billion
Hanger, Inc. (NYSE: HNGR) is a provider of orthotic and prosthetic services at its 875 Hanger Clinic locations located around...
Read more
NexImmune (NASDAQ: NEXI) Says FDA Granted IND Clearance for NEXI-003 and Treatment of HPV-Based Cancers
NexImmune, Inc. (NASDAQ: NEXI) is engaged as a clinical-stage biotechnology company, which is focused on developing new, novel immunotherapy treatments...
Read more
Iterum Therapeutics (NASDAQ: ITRM) Reaches Special Protocol Assessment Agreement (SPA) with U.S. FDA
Iterum Therapeutics plc (NASDAQ: ITRM) is engaged as a clinical-stage pharmaceutical company, which is focused on the research and development...
Read more
Inspira Technologies (NASDAQ: IINN) Unveils Non-Invasive Blood Sensor that Provides Real-Time Changes in Patients
Inspira Technologies OXY B.H.N., Ltd. (NASDAQ: IINN) is engaged as a medical technology company that is focused on the research,...
Read more
5 Best Performing Micro-Cap Stocks Through the First Half of 2022
The first half of 2022 is finally in the books and it could not have come sooner. Major U.S. indices...
Read more
Emergent Health Corp. (OTC Pink: EMGE) Announces LOI to Acquire Fusion Specialty Pharmacy
Emergent Health Corp. (OTC Pink: EMGE) is focused on the development and sale of products within the regenerative health industry....
Read more
